Adaptogenics Health Corp.
CCSE:ADPTTotal Valuation
CADAs of June 30, 2026, Adaptogenics Health Corp. carries a market capitalization of 122,982.72, placing it among publicly traded companies globally. Its enterprise value stands at 97,401.72, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 122,982.72 |
| Enterprise Value | 97,401.72 |
Share Statistics
As of June 30, 2026, Adaptogenics Health Corp. has 1.02M shares outstanding.
| Shares Outstanding | 1.02M |
Valuation Ratios
These figures are as of June 30, 2026.
| PB Ratio | -6.26 |
| P/TBV Ratio | -6.26 |
Financial Position
As of June 30, 2026, Adaptogenics Health Corp. maintains a current ratio of 0.58, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.58 |
| Quick Ratio | 0.58 |
Stock Price Statistics
CADAs of the close on October 22, 2026, Adaptogenics Health Corp.'s stock has gained approximately 200.00% over the past 52 weeks. The 50-day moving average sits at 0.15, while the 200-day moving average is 0.12.
| 52-Week Price Change | 200.00% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.12 |
Income Statement
CADThese figures cover the twelve months ended June 30, 2026.
| Pretax Income | -14,406.00 |
Balance Sheet
CADThese figures are as of June 30, 2026. Total book value stands at -19,651.00, with working capital of -19,651.00 providing operational flexibility.
| Cash & Cash Equivalents | 25,581.00 |
| Net Debt | -25,581.00 |
| Equity (Book Value) | -19,651.00 |
| Book Value Per Share | -0.02 |
| Working Capital | -19,651.00 |
Cash Flow
CADThese figures cover the twelve months ended June 30, 2026.
| Free Cash Flow | -11,643.00 |
| FCF Per Share | -0.01 |
Stock Splits
Adaptogenics Health Corp.'s most recent stock split took place on August 5, 2026 with a 4:1 split ratio.
| Last Split Date | 8/5/2026 |
| Split Ratio | 4:1 |